Lazertinib

Lazertinib (YH25448) is a potent, highly mutant-selective, blood-brain barrier permeable, orally available and irreversible third-generation EGFR tyrosine kinase inhibitor.


Cat. No.: EX-A1912	Purity: >99%

	Chemical structure of Lazertinib

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
250mg	400	In-stock
500mg	600	In-stock
1g	900	In-stock
5g	2780	In-stock
10g	4200	In-stock
25g	6860	In-stock

Send PO to E-mail:order@excenen.com; or Fax:+86 020 81619670

Discount Request


Synonyms	YH25448
Synonyms 2	GNS-1480
CAS No.	1903008-80-9
Purity	>99%
Formula	C30H34N8O3
Mol Weight	554.6428
Appearance	light yellow to yellow solid powder
Solubility	Soluble in DMSO
Shelf Life	>2 years if stored properly
Storage	Powder -20℃ 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Byoung Chul Cho, et al. YH25448, a 3rd Generation EGFR-TKI, in Patients with EGFR-TKI-resistant NSCLC: Phase I/II Study Results.
CoA	CoA of Lazertinib

Smiles:	COC1=C(NC2=NC=CC(=N2)N2C=C(CN(C)C)C(=N2)C2=CC=CC=C2)C=C(NC(=O)C=C)C(=C1)N1CCOCC1


		Search